semaglutide monroe la REJUVIME MEDICAL - Updated July 2026 - 2571 Tower Dr, Monroe, Louisiana - Weight Loss Centers - Phone Number Semaglutide for Weight Loss: Before

When GLP- 1 receptor agonists are used to treat T2DM, there is also a noticeable reduction in post-meal glycemic fluctuations due to their short-term, transient effect on slowing gastric emptying

Half remains

In comparison, patients who used retatrutide (8 mg and 12 mg once weekly) lost 17.5% at 24 weeks and 24.2% of their body weight after 48 weeks in phase 2 clinical trials

I have had patients complain of thinning hair and hair loss after significant weight loss

For patients who find weekly semaglutide's prolonged nausea intolerable, this pharmacokinetic difference is clinically relevant

Potential Side Effects and Safety Considerations Gastrointestinal adverse effects are the most commonly reported side effects of GLP-1 receptor agonists, occurring in a significant proportion of patients, particularly during treatment initiation and dose escalation